Kamada Ltd. (NASDAQ:KMDA) Declares Annual Dividend of $0.25

Kamada Ltd. (NASDAQ:KMDA) declared an annual dividend on Wednesday, March 11th. Stockholders of record on Monday, March 23rd will be paid a dividend of 0.25 per share by the biotechnology company on Monday, April 6th. This represents a dividend yield of 292.0%. The ex-dividend date of this dividend is Monday, March 23rd.

Kamada Price Performance

KMDA opened at $8.55 on Thursday. Kamada has a one year low of $5.54 and a one year high of $9.35. The business has a 50 day simple moving average of $8.38 and a two-hundred day simple moving average of $7.44. The firm has a market capitalization of $491.71 million, a price-to-earnings ratio of 23.75, a PEG ratio of 0.75 and a beta of 0.94.

About Kamada

Kamada Ltd. is a biopharmaceutical company headquartered in Israel that specializes in the development, manufacturing and commercialization of plasma‐derived protein therapeutics. The company focuses on treatments for rare and serious diseases, leveraging its proprietary fractionation and purification technologies to produce purified human proteins. Kamada’s product portfolio addresses critical therapeutic areas in immunology, hematology and pulmonology, where alternative treatment options may be limited.

Among Kamada’s marketed products is Glassia®, an alpha‐1 antitrypsin augmentation therapy approved by the U.S.